PSI Careers - Lunch & Learn: Imposter Syndrome Session

PSI Training Course: Introduction to Machine Learning

This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.

Joint PSI/EFSPI Vaccine SIG Webinar: Statistical and Mechanistic Models for Correlates of Protection

This webinar will explore two different approaches to Correlates of Protection in vaccine development.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Webinar: Drug Development in Women's Health

The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.

PSI Webinar: Surrogacy

This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.

Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies

Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.

Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium

We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.

PSI Career Young Virtual Event (Q2 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q3 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Introduction to Industry Training (ITIT) Course - 2024/2025

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

PSI Career Young Virtual Event (Q4 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Speaker	Biography
Chrissie Fletcher (GSK)	Chrissie is the Vice President of Development Statistics at GlaxoSmithKline.She has worked in the Pharmaceutical Industry for 30 years and has experience of developing and commercialising new medicines in a variety of clinical disease areas across all phases of clinical development. Chrissie is actively engaged in statistical societies, pharmaceutical trade associations and initiatives relating to the Pharmaceutical Industry such as driving innovation in clinical trials and sharing implementation experiences of ICH E9(R1) and adoption of the new estimand framework.
Claire Brittain (UCB)	Claire has worked in medical statistics for over 15 years with most of those years in early phase pharmaceuticals. She has worked at GSK, Eli Lilly and UCB primarily in neuroscience and immunology, then more recently in COVID-19. Claire has a keen interest in translational and methodology studies and enjoys making statistics pragmatic and keeping science at the heart of any discussion.
Paul Terril (PT Stat Consulting)	After completing his PhD in statistics Paul started his career working as a statistician in the agrochemical industry before becoming a statistical trainer for SAS. He moved into the pharmaceutical industry in 2005 and worked for several CROs before becoming an independent consultant in 2020. Paul primarily provides support to biotech and small pharmaceutical companies who lack in-house statistical expertise.
Anashua Banerji (Cytel)	Anashua Banerji has cross-functional experience of more than 11 years in mathematical modeling, biostatistics, business strategy consulting and technology product management in healthcare. In her current role at Cytel, Anashua is focusing on adaptive designs, enrichment strategies, and applications of data science to real world data to mine insights relevant for trial design and stake-holder decision-making.

Event